文献速递糖尿病

对所有孕前糖尿病孕妇实施预防性阿司匹林后子痫前期患病率未变:一项前瞻性队列研究

Unchanged Prevalence of Preeclampsia After Implementation of Prophylactic Aspirin for All Pregnant Women With Preexisting Diabetes: A Prospective Cohort Study.
PubMed 文献 · Diabetes Care · 2021-01-01

该前瞻性观察队列纳入410例孕前糖尿病孕妇,比较2018年2月后对所有孕妇实施预防性阿司匹林(全队列207例)与之前基于风险选择用药(选择队列203例)的子痫前期患病率。全队列88%在约10孕周处方阿司匹林,选择队列为25%;两队列子痫前期患病率相似(12% vs 11%,P=0.69),早产、早发型子痫前期及大于/小于胎龄儿比例亦无差异。

要点

  • 对所有孕前糖尿病孕妇预防性使用阿司匹林未降低子痫前期患病率。
  • 全队列阿司匹林处方率88%,选择队列25%,但子痫前期仍为12% vs 11%。
  • 早产、早发型子痫前期及大于/小于胎龄儿比例在两队列间无显著差异。

核心结论

  • 与既往基于风险预防相比,对所有孕前糖尿病孕妇实施预防性阿司匹林未降低子痫前期患病率。

研究设计与样本

  • 前瞻性观察性队列研究,纳入410例连续孕前糖尿病孕妇,按阿司匹林预防策略分为全队列207例和选择队列203例。

主要发现

  • 全队列88%在约10孕周处方阿司匹林,选择队列为25%。
  • 两队列子痫前期患病率相似(12% vs 11%,P=0.69),按糖尿病类型分层后亦相似。
  • 早产<37周(23% vs 27%,P=0.30)、早发型子痫前期(7% vs 7%,P=0.96)、大于胎龄儿(40% vs 32%,P=0.07)及小于胎龄儿(7% vs 6%,P=0.88)比例均相似。
  • 全队列2型糖尿病比例较低(32% vs 42%,P=0.04),BMI有更低趋势(P=0.05)。

临床怎么用

  • 对孕前糖尿病孕妇,预防性阿司匹林策略需权衡,不应假定普遍用药即可降低子痫前期风险。

局限性

  • 为观察性队列研究,非随机对照,可能存在残余混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the prevalence of preeclampsia after implementation of prophylactic aspirin for all pregnant women with preexisting diabetes compared with the prevalence in a previous risk-based prophylaxis. RESEARCH DESIGN AND METHODS: A prospective observational cohort study of 410 consecutive pregnant women with preexisting diabetes categorized according to aspirin prophylaxis strategy, with the prevalence of preeclampsia as primary outcome. In total, 207 women were included after implementation of prophylactic aspirin for all pregnant women with preexisting diabetes in February 2018 (all-cohort). The 203 women included before this date, where aspirin prophylaxis was risk based and only prescribed to selected women (selected-cohort), were studied for comparison. RESULTS: Aspirin was prescribed at ∼10 gestational weeks for 88% (all-cohort) compared with 25% (selected-cohort). HbA1c, parity, chronic hypertension, home blood pressure, microalbuminuria/diabetic nephropathy, and smoking were similar in the two cohorts in early pregnancy. In the all-cohort, fewer women had type 2 diabetes (32% vs. 42%, respectively; P = 0.04) and BMI tended to be lower (P = 0.05). The prevalence of preeclampsia was similar (12% vs. 11%, P = 0.69) in the two cohorts, and this was also the case with stratification for diabetes type. Prevalence of preterm delivery <37 weeks (23% vs. 27%, P = 0.30), preterm preeclampsia (7% vs. 7%, P = 0.96), and infants large (40% vs. 32%, P = 0.07) and small (7% vs. 6%, P = 0.88) for gestational age was similar in the two cohorts. CONCLUSIONS: Implementation of prophylactic aspirin for all pregnant women with diabetes did not reduce the prevalence of preeclampsia compared with the previous risk-based prophylaxis in this cohort study.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Do NC, Vestgaard M, Ásbjörnsdóttir B, et al. Unchanged Prevalence of Preeclampsia After Implementation of Prophylactic Aspirin for All Pregnant Women With Preexisting Diabetes: A Prospective Cohort Study. Diabetes Care. 2021. PMID: 34400481. doi:10.2337/dc21-1182

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。